Literature DB >> 23458726

Preparation of archival formalin-fixed paraffin-embedded mouse liver samples for use with the Agilent gene expression microarray platform.

A Francina Jackson1, Andrew Williams2, Ivy Moffat2, Suzanne L Phillips3, Leslie Recio3, Michael D Waters3, Iain B Lambert4, Carole L Yauk2.   

Abstract

INTRODUCTION: Tissue samples are routinely formalin-fixed and paraffin-embedded (FFPE) for long term preservation. Gene expression analysis of archival FFPE tissues may advance knowledge of the molecular perturbations contributing to disease. However, formalin causes extensive degradation of RNA.
METHODS: We compared RNA quality/yield from FFPE samples using six commercial FFPE RNA extraction kits. In addition we compared four DNA microarray protocols for the Agilent 8×60K platform using 16year old FFPE mouse liver samples treated with phenobarbital or vehicle.
RESULTS: Despite low quality RNA, archival phenobarbital samples exhibited strong induction of the positive control genes Cyp2b9 and Cyp2b10 by quantitative real-time PCR (qPCR). We tested one- and two-color microarray designs and evaluated the effects of increasing the amount of hybridized cDNA. Canonical gene responders to phenobarbital were measurably induced under each experimental condition. Increasing the amount of labeled cDNA did not improve the overall signal intensity. One-color experiments yielded larger fold changes than two-color and the number of differentially expressed genes varied between protocols. Gene expression changes were validated by qPCR and literature searches. Individual protocols exhibited high rates of false positives; however, pathway analysis revealed that nine of the top ten canonical pathways were consistent across experiments. Genes that were differentially expressed in more than one experiment were more likely to be validated. Thus, we recommend that experiments on FFPE samples be done in duplicate to reduce false positives. DISCUSSION: In this analysis of archival FFPE samples we were able to identify pathways that are consistent with phenobarbital's mechanism of action. Therefore, we conclude that FFPE samples can be used for meaningful microarray gene expression analyses. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1.5X; 1C; 1X; 2C; Archival tissue; CAR; Cy; Cyp; DEG; FF; FFPE; Formalin-fixed paraffin-embedded (FFPE); Gene expression; IPA; Ingenuity Pathway Analysis; K; LOWESS; LincRNA; MAANOVA; Microarray (Agilent); PCR; PXR; Phenobarbital; RIN; RNA; RNA integrity number; RXR; SD; ULS; Universal Linkage System; WTA; cDNA; complementary deoxyribonucleic acid; constitutive androstane receptor; cyanine; cytochrome P450; dT; deoxy-thymine; differentially expressed gene; formalin-fixed paraffin-embedded; fresh-frozen; high cDNA input; locally weighted scatterplot smoothing; long intergenic non-coding RNA; microarray analysis of variance; normal cDNA input; oligo; oligonucleotide; one-color; polymerase chain reaction; pregnane X receptor; qPCR; quantitative PCR; retinoid X receptor; ribonucleic acid; standard deviation; thousand; two-colour; whole transcriptome amplification

Mesh:

Substances:

Year:  2013        PMID: 23458726     DOI: 10.1016/j.vascn.2013.02.008

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  2 in total

1.  Mining the Archives: A Cross-Platform Analysis of Gene Expression Profiles in Archival Formalin-Fixed Paraffin-Embedded Tissues.

Authors:  A Francina Webster; Paul Zumbo; Jennifer Fostel; Jorge Gandara; Susan D Hester; Leslie Recio; Andrew Williams; Charles E Wood; Carole L Yauk; Christopher E Mason
Journal:  Toxicol Sci       Date:  2015-09-10       Impact factor: 4.849

2.  Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.

Authors:  Jungnam Lee; Ivan Arisi; Ermanno Puxeddu; Lazarus K Mramba; Massimo Amicosante; Carmen M Swaisgood; Marco Pallante; Mark L Brantly; C Magnus Sköld; Cesare Saltini
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.